• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的线粒体功能障碍——蛋白质组学视角。

Mitochondrial dysfunction in Alzheimer's disease - a proteomics perspective.

机构信息

Cell Science Research Center, Department of Molecular Systems Biology, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran Iran.

Department of Clinical Medicine, Macquarie University, Macquarie Park, NSW, Australia.

出版信息

Expert Rev Proteomics. 2021 Apr;18(4):295-304. doi: 10.1080/14789450.2021.1918550. Epub 2021 May 3.

DOI:10.1080/14789450.2021.1918550
PMID:33874826
Abstract

Mitochondrial dysfunction is involved in Alzheimer's disease (AD) pathogenesis. Mitochondria have their own genetic material; however, most of their proteins (∼99%) are synthesized as precursors on cytosolic ribosomes, and then imported into the mitochondria. Therefore, exploring proteome changes in these organelles can yield valuable information and shed light on the molecular mechanisms underlying mitochondrial dysfunction in AD. Here, we review AD-associated mitochondrial changes including the effects of amyloid beta and tau protein accumulation on the mitochondrial proteome. We also discuss the relationship of ApoE genetic polymorphism with mitochondrial changes, and present a meta-analysis of various differentially expressed proteins in the mitochondria in AD.: Proteomics studies and their contribution to our understanding of mitochondrial dysfunction in AD pathogenesis.: Proteomics has proven to be an efficient tool to uncover various aspects of this complex organelle, which will broaden our understanding of mitochondrial dysfunction in AD. Evidently, mitochondrial dysfunction is an early biochemical event that might play a central role in driving AD pathogenesis.

摘要

线粒体功能障碍与阿尔茨海默病(AD)的发病机制有关。线粒体有自己的遗传物质;然而,它们的大多数蛋白质(~99%)都是在线粒体核糖体上作为前体合成的,然后被导入线粒体。因此,探索这些细胞器中的蛋白质组变化可以提供有价值的信息,并阐明 AD 中线粒体功能障碍的分子机制。在这里,我们回顾了与 AD 相关的线粒体变化,包括淀粉样β和tau 蛋白积累对线粒体蛋白质组的影响。我们还讨论了 ApoE 遗传多态性与线粒体变化的关系,并对 AD 中线粒体中各种差异表达蛋白进行了荟萃分析:蛋白质组学研究及其对我们理解 AD 发病机制中线粒体功能障碍的贡献:蛋白质组学已被证明是揭示这个复杂细胞器的各个方面的有效工具,这将拓宽我们对 AD 中线粒体功能障碍的理解。显然,线粒体功能障碍是早期的生化事件,可能在驱动 AD 发病机制中发挥核心作用。

相似文献

1
Mitochondrial dysfunction in Alzheimer's disease - a proteomics perspective.阿尔茨海默病中的线粒体功能障碍——蛋白质组学视角。
Expert Rev Proteomics. 2021 Apr;18(4):295-304. doi: 10.1080/14789450.2021.1918550. Epub 2021 May 3.
2
Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.阿尔茨海默病 APP/PS1 小鼠模型中线粒体相关膜蛋白的早期无症状变化。
Mol Neurobiol. 2018 Oct;55(10):7839-7857. doi: 10.1007/s12035-018-0955-6. Epub 2018 Feb 22.
3
Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.阿尔茨海默病的蛋白质组学全景:发病机制和生物标志物发现的新见解。
Mol Neurodegener. 2021 Aug 12;16(1):55. doi: 10.1186/s13024-021-00474-z.
4
Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease.阿尔茨海默病 APP/PS1 和 ApoE4 转基因小鼠模型早期线粒体变化的蛋白质组学特征。
J Proteome Res. 2019 Jun 7;18(6):2632-2642. doi: 10.1021/acs.jproteome.9b00136. Epub 2019 May 13.
5
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.突触线粒体:阿尔茨海默病中淀粉样β和tau 的早期靶标。
J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139.
6
Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.通过定量蛋白质组学评估新型阿尔茨海默病小鼠模型中的分子和功能特征。
Mol Neurodegener. 2018 Jan 16;13(1):2. doi: 10.1186/s13024-017-0234-4.
7
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.线粒体功能障碍在阿尔茨海默病发病机制中的作用:最新进展
Mol Neurodegener. 2020 May 29;15(1):30. doi: 10.1186/s13024-020-00376-6.
8
The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.线粒体功能障碍在阿尔茨海默病发病机制中的作用。
Alzheimers Dement. 2023 Jan;19(1):333-342. doi: 10.1002/alz.12683. Epub 2022 May 6.
9
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease.定量分析脑蛋白质组学揭示了阿尔茨海默病中的线粒体功能障碍。
Mol Brain. 2019 Jan 28;12(1):8. doi: 10.1186/s13041-019-0430-y.
10
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.

引用本文的文献

1
Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities.阿尔茨海默病中的线粒体损伤与自噬失调:机制与治疗机遇
Neurochem Res. 2025 Jul 28;50(4):251. doi: 10.1007/s11064-025-04490-z.
2
Multiomics from Alzheimer's Brains and Mesenchymal Stem Cell-Derived Extracellular Vesicles Identifies Therapeutic Potential of Specific Subpopulations to Target Mitochondrial Proteostasis.来自阿尔茨海默病大脑和间充质干细胞衍生细胞外囊泡的多组学研究确定了特定亚群针对线粒体蛋白质稳态的治疗潜力。
J Cent Nerv Syst Dis. 2025 Apr 23;17:11795735251336302. doi: 10.1177/11795735251336302. eCollection 2025.
3
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.
基于2型糖尿病所致脑能量代谢变化的阿尔茨海默病病理学与治疗方法
Molecules. 2024 Dec 16;29(24):5936. doi: 10.3390/molecules29245936.
4
Proteomic profiling of mesenchymal stem cell-derived extracellular vesicles: Impact of isolation methods on protein cargo.间充质干细胞衍生的细胞外囊泡的蛋白质组学分析:分离方法对蛋白质载量的影响。
J Extracell Biol. 2024 Jun 6;3(6):e159. doi: 10.1002/jex2.159. eCollection 2024 Jun.
5
Application of Multiomics Approach to Investigate the Therapeutic Potentials of Stem Cell-derived Extracellular Vesicle Subpopulations for Alzheimer's Disease.应用多组学方法研究干细胞衍生细胞外囊泡亚群对阿尔茨海默病的治疗潜力。
bioRxiv. 2024 May 14:2024.05.10.593647. doi: 10.1101/2024.05.10.593647.
6
Amyloid-beta and tau protein beyond Alzheimer's disease.阿尔茨海默病之外的β淀粉样蛋白和tau蛋白。
Neural Regen Res. 2024 Jun 1;19(6):1262-1276. doi: 10.4103/1673-5374.386406. Epub 2023 Oct 2.
7
Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease.阿尔茨海默病线粒体靶向干预的当前进展
Biomedicines. 2023 Aug 22;11(9):2331. doi: 10.3390/biomedicines11092331.
8
Common molecular signatures between coronavirus infection and Alzheimer's disease reveal targets for drug development.冠状病毒感染与阿尔茨海默病之间的共同分子特征揭示了药物开发的靶点。
bioRxiv. 2023 Jun 15:2023.06.14.544970. doi: 10.1101/2023.06.14.544970.
9
Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases.载脂蛋白ε与脑和视网膜神经退行性疾病
Aging Dis. 2023 Aug 1;14(4):1311-1330. doi: 10.14336/AD.2023.0312-1.
10
Oxidative Stress Induced Dysfunction of Protein Synthesis in 661W Mice Photoreceptor Cells.氧化应激诱导661W小鼠光感受器细胞中蛋白质合成功能障碍。
Proteomes. 2023 Apr 3;11(2):12. doi: 10.3390/proteomes11020012.